Hospital Israelita Albert Einstein
Clinical trials sponsored by Hospital Israelita Albert Einstein, explained in plain language.
-
New hope for sickle cell: High-Dose drug may boost stem cell harvest
Disease control Not yet recruitingThis study tests whether a high dose of plerixafor can safely collect enough stem cells from people with sickle cell disease for a future transplant. About 12 participants aged 18-25 will receive transfusions, take the drug, and have stem cells collected through a process called …
Phase: PHASE1, PHASE2 • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Can a text message speed up your ER Follow-Up?
Knowledge-focused Not yet recruitingThis study compares two ways of contacting patients after they leave the emergency department. One group gets a standard phone call, while the other also receives text reminders and app instructions to check their lab results. The goal is to see which method helps patients connec…
Phase: NA • Sponsor: Hospital Israelita Albert Einstein • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
New registry to track sepsis patients after hospital discharge
Knowledge-focused Not yet recruitingThis study is a registry that will follow 760 adults hospitalized with sepsis. Researchers will collect information on how patients are treated in the hospital and what happens to them after they leave, including survival and heart-related problems. The goal is to better understa…
Sponsor: Hospital Israelita Albert Einstein • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC